Maverick Capital Ltd. Has $684,000 Position in Trupanion, Inc. $TRUP

Maverick Capital Ltd. lowered its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 80.0% in the first quarter, Holdings Channel.com reports. The firm owned 26,714 shares of the financial services provider’s stock after selling 107,159 shares during the period. Maverick Capital Ltd.’s holdings in Trupanion were worth $684,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Tudor Investment Corp ET AL lifted its stake in Trupanion by 183.7% in the 3rd quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock worth $10,263,000 after acquiring an additional 153,530 shares in the last quarter. Polar Capital Holdings Plc boosted its position in Trupanion by 13.5% during the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after acquiring an additional 175,000 shares during the period. Hosking Partners LLP grew its stake in Trupanion by 8.1% during the 4th quarter. Hosking Partners LLP now owns 465,950 shares of the financial services provider’s stock valued at $17,413,000 after acquiring an additional 35,020 shares in the last quarter. R Squared Ltd grew its stake in Trupanion by 44.7% during the 4th quarter. R Squared Ltd now owns 9,075 shares of the financial services provider’s stock valued at $339,000 after acquiring an additional 2,803 shares in the last quarter. Finally, Illinois Municipal Retirement Fund increased its holdings in shares of Trupanion by 2.3% in the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after purchasing an additional 406 shares during the period.

Insiders Place Their Bets

In other news, COO John R. Gallagher sold 3,603 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the transaction, the chief operating officer owned 33,065 shares in the company, valued at $717,179.85. This represents a 9.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the transaction, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This represents a 7.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 17,376 shares of company stock valued at $383,642 over the last ninety days. Corporate insiders own 5.58% of the company’s stock.

Trupanion Trading Up 2.5%

Shares of NASDAQ TRUP opened at $25.50 on Wednesday. The business has a 50 day simple moving average of $24.14 and a 200 day simple moving average of $26.64. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $57.00. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of 43.22 and a beta of 1.39. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.04. The firm had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.03) earnings per share. On average, research analysts predict that Trupanion, Inc. will post 0.55 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

TRUP has been the subject of a number of research analyst reports. Cantor Fitzgerald reduced their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Bank of America cut their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Finally, Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a research note on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Trupanion presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.